Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection

Bibliographic Details
Main Authors:	Rubhana Raqib, Malabi Venkatesan
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396421001365

id	doaj-e69cf83ec9f84a37b7f7208b864d5467
record_format	Article
spelling	doaj-e69cf83ec9f84a37b7f7208b864d54672021-04-30T07:22:56ZengElsevierEBioMedicine2352-39642021-04-0166103343Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protectionRubhana Raqib0Malabi Venkatesan1Infectious Diseases Division, icddr,b, Dhaka, Bangladesh; Corresponding author.Department of Enteric Infections, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Maryland, USA (recently retired)http://www.sciencedirect.com/science/article/pii/S2352396421001365
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Rubhana Raqib Malabi Venkatesan
spellingShingle	Rubhana Raqib Malabi Venkatesan Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection EBioMedicine
author_facet	Rubhana Raqib Malabi Venkatesan
author_sort	Rubhana Raqib
title	Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection
title_short	Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection
title_full	Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection
title_fullStr	Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection
title_full_unstemmed	Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection
title_sort	shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection
publisher	Elsevier
series	EBioMedicine
issn	2352-3964
publishDate	2021-04-01
url	http://www.sciencedirect.com/science/article/pii/S2352396421001365
work_keys_str_mv	AT rubhanaraqib shigellaconjugatevaccineefficacytrialincontrolledhumanmodelandpotentialimmunecorrelatesofprotection AT malabivenkatesan shigellaconjugatevaccineefficacytrialincontrolledhumanmodelandpotentialimmunecorrelatesofprotection
_version_	1721498665238921216

Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection

Similar Items